Bone marrow mesenchymal stem cells protect against retinal ganglion cell loss in aged rats with glaucoma

40Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

Abstract

Glaucoma is a common eye disease in the aged population and has severe consequences. The present study examined the therapeutic effects of bone marrow mesenchymal stem cell (BMSC) transplantation in preventing loss of visual function in aged rats with glaucoma caused by laser-induced ocular hypertension. We found that BMSCs promoted survival of retinal ganglion cells in the transplanted eye as compared with the control eye. Further, in swimming tests guided by visual cues, the rats with a BMSC transplant performed significantly better. We believe that BMSC transplantation therapy is effective in treating aged rats with glaucoma. © 2013 Hu et al, publisher and licensee Dove Medical Press Ltd.

Cite

CITATION STYLE

APA

Hu, Y., Tan, H. B., Wang, X. M., Rong, H., Cui, H. P., & Cui, H. (2013). Bone marrow mesenchymal stem cells protect against retinal ganglion cell loss in aged rats with glaucoma. Clinical Interventions in Aging, 8, 1467–1470. https://doi.org/10.2147/CIA.S47350

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free